BioTalk with Rich Bendis

BioHealth Innovation, Inc. (BHI)

BioHealth Innovation, Inc. (BHI) Founder, President & CEO, Rich Bendis, hosts BioTalk — conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry. BioTalk enables you to learn from these leaders about issues which can help you grow your business. What are the current trends? Where are industry sectors headed? How do we increase access to capital in our region? Rich and his guests dive deep into these topics and much more. Host, Rich Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker, and consultant in the technology and biohealth industries. Produced by Andy Eckert, with help from The Podcast Consultant, Mathew Passy.

  1. 1d ago

    BioFactura's CDMO Evolution: Jeffrey Hausfeld and Darryl Sampey on Capitol Biologics

    In this episode of BioTalk with Rich Bendis, Jeffrey N. Hausfeld, M.D., Chairman of the Board and Chief Medical Officer of BioFactura Inc., and Darryl Sampey, Ph.D., President and Chief Executive Officer of Capitol Biologics, join the conversation to discuss the launch of Capitol Biologics as BioFactura's CDMO division. Jeff and Darryl explain how BioFactura's experience building biologics development and clinical manufacturing capabilities created the foundation for a more personalized CDMO model. The discussion explores the gap Capitol Biologics is designed to fill for emerging biotech companies that need integrated development support, scientific depth, analytical expertise, phase-appropriate quality, and early GMP manufacturing without being pushed into a large commercial-scale CDMO model too soon. The conversation also highlights what biotech CEOs and CMC leaders should consider before choosing a CDMO partner, including developability assessment, cell line and process development, analytical characterization, quality systems, cost of goods, regulatory readiness, and timing. Jeff and Darryl also discuss the growing importance of U.S.-based biologics development and manufacturing capacity, especially for emerging biotech and government-aligned programs. Editing and post-production work for this episode was provided by The Podcast Consultant. Jeffrey N. Hausfeld, M.D., M.B.A., F.A.C.S., is a physician entrepreneur, biotechnology executive, investor, and healthcare innovator whose career spans clinical medicine, life sciences, healthcare real estate development, and entrepreneurial leadership. A graduate of Yale University School of Medicine and recipient of an M.B.A. from Johns Hopkins University, Dr. Hausfeld is an Associate Clinical Professor of Surgery at George Washington University and has been actively involved in national medical societies and healthcare leadership organizations for more than four decades. He currently serves as Chairman of the Board and Chief Medical Officer of BioFactura Inc., Chairman of Capitol Biologics, and Chairman and Co-Founder of the Society of Physician Entrepreneurs. His work focuses on advancing healthcare innovation, biotechnology commercialization, physician entrepreneurship, and the responsible adoption of emerging technologies that improve patient care. Darryl Sampey, Ph.D., is a biopharmaceutical executive and company builder with more than 30 years of experience advancing biologics from discovery through clinical development and commercial manufacturing. He co-founded BioFactura in 2004 and has guided the company from start-up through incubator stages into a fully integrated biopharmaceutical product development and clinical manufacturing company. At BioFactura, he has raised more than $90 million in non-dilutive and strategic funding, built cGMP manufacturing capabilities, and led development of novel therapeutics, biodefense medical countermeasures, biosimilars, and cell therapies. Dr. Sampey is an inventor of the VeriCyte™ Discovery and StableFast™ Biomanufacturing Platforms and previously held process development and manufacturing leadership roles at Human Genome Sciences and North American Vaccine.

    39 min

  2. May 31

    From Personal Mission to FDA Clearance: Neal Piper on Luminoah's Next Chapter in Tube Feeding Innovation

    In this episode of BioTalk with Rich Bendis, Neal Piper, Founder and CEO of Luminoah, returns to share a major milestone in the company's journey: FDA clearance for Luminoah Flow. A past winner of the BioHealth Capital Region Crab Trap Competition, Neal first joined BioTalk to discuss the deeply personal story behind the company. His family's experience during his son Noah's cancer treatment revealed the daily challenges of tube feeding, from limited mobility and caregiver burden to the lack of real-time data once patients leave the hospital. Now, after six years of development, persistence, regulatory work, and product refinement, Luminoah is preparing to bring its portable, connected enteral nutrition system to patients, caregivers, clinicians, and health systems. Neal discusses what FDA clearance means for the company, how Luminoah Flow is designed to support more independence in daily life, and what comes next as the team prepares for early access programs, commercial rollout, and continued growth in the BioHealth Capital Region. Editing and post-production work for this episode was provided by The Podcast Consultant. Neal Piper has devoted his career to advancing healthcare and expanding access to life-saving innovation across the U.S., Africa, and Asia. He began in Pfizer's Neuroscience Division before joining the Global Health Fellows Program, later serving as President of its Alumni Business Network, where he united 350 leaders and scientists to strengthen healthcare systems worldwide. He went on to expand healthcare programs in 18 countries with Population Services International and founded multiple ventures, including a home healthcare company. As the founding CEO of the Presidential Precinct, he empowered emerging and world leaders driving change in government, entrepreneurship, and civil society. Guided by a belief in the power of innovation to improve lives, Neal now leads Luminoah with a mission to create meaningful, lasting change in healthcare.

    39 min

  3. May 25

    How ARPA-H Is Opening New Doors for Small Businesses: Sam Gussman-Toh on Funding, Commercialization, and Breakthrough Health Innovation

    In this episode of BioTalk with Rich Bendis, Sam Gussman-Toh, Portfolio Manager for the Small Business Program at ARPA-H, joins the conversation to discuss how the agency is creating new pathways for small businesses developing ambitious health technologies. Sam explains how the ARPA-H model differs from traditional federal funding programs, with a focus on moonshot health solutions, program manager-led portfolios, milestone-driven contracts, and a strong emphasis on moving technologies toward real-world use. He also discusses how the Small Business Program supports SBIR and STTR performers through Phase I, Phase II, Direct to Phase II, and Fast Track awards. The conversation highlights how ARPA-H is working with ambitious small businesses, including non-traditional companies and early-stage startups that may be working with the federal government for the first time. Sam also shares how commercialization support is built into the program, including ARPA-H's Entrepreneur-in-Residence partnership with BioHealth Innovation. Through that relationship, BHI EIRs help performers strengthen regulatory strategy, intellectual property planning, go-to-market strategy, reimbursement considerations, and other key commercialization needs. Sam also discusses ARPA-H's draft Small Business Program solicitation, the upcoming virtual Proposers' Day on June 11, and what companies should know about the application process, topic areas, technical pitches, and future funding opportunities. Editing and post-production work for this episode was provided by The Podcast Consultant. Sam Gussman-Toh is Portfolio Manager for the Small Business Program at ARPA-H, where he coordinates and oversees the agency's SBIR/STTR awards and commercialization support services for participating small businesses. Sam joined ARPA-H in 2022 and wrote the agency's first SBIR/STTR solicitation. He has held several roles in the Office of Commercialization and has worked closely with Program Managers to build the agency's commercialization infrastructure and strategy. Previously, Sam designed and managed rapid prototyping programs across agencies in the Department of War. His technical background is in computer science, with interests in computer vision, autonomous robotic systems, and computational pathology.

    35 min

  4. May 17

    Building Montgomery County's Next Chapter: MCEDC's Jared Smith on Talent, Partnerships, and the Future of Economic Development

    In this episode of BioTalk with Rich Bendis, Jared Smith, MBA, CEcD, President and CEO of the Montgomery County Economic Development Corporation, joins the conversation to discuss his new role leading economic development efforts in one of the nation's most important biohealth markets. Jared shares how his experience in Louisiana and Nevada shaped his approach to economic development, including the importance of diversification, business retention, workforce strategy, and bringing partners together around shared goals. He also explains MCEDC's role as a public-private partnership and how the organization works with local government, chambers, business leaders, nonprofits, academic institutions, and other stakeholders to support companies across Montgomery County. The discussion highlights the county's deep talent base, global diversity, quality of life, and position as the center of a top U.S. biopharma hub. Jared also discusses MCEDC's strategic planning process, the importance of reducing uncertainty for companies, and why economic development should be viewed as an investment in long-term community strength. Throughout the episode, Jared emphasizes that MCEDC is focused on listening, connecting the right people, helping companies navigate available resources, and building a more competitive future for Montgomery County. Editing and post-production work for this episode was provided by The Podcast Consultant. https://thepodcastconsultant.com/ Jared Smith serves as the President and CEO of the Montgomery County Economic Development Corporation, where he leads economic development initiatives to attract, retain, and expand businesses within key industries in Montgomery County, Maryland. Jared joined MCEDC in December 2025 after spending more than a decade in Nevada's economic development ecosystem. As Director of Economic Development for the City of Henderson, he supported a community within the Las Vegas Metropolitan Statistical Area of more than two million residents. During his tenure, he played a key role in diversifying a tourism-driven regional economy and supported the creation of more than 20,000 jobs. Previously, as Chief Operating Officer of the Las Vegas Global Economic Alliance, he helped deliver $17.2 billion in regional economic impact, the highest in the organization's history. His economic development and business experience spans business attraction, retention, and expansion, as well as workforce development and long-term strategic planning. He has collaborated with companies across a wide range of industries, from established businesses to high-growth sectors. Before moving to Nevada, Jared was Director of Business Development at the Baton Rouge Area Chamber and Manager of Business Retention and Expansion at Louisiana Economic Development, where he designed and deployed a comprehensive economic development strategy and outreach program to expand corporate businesses statewide. Throughout his career, Jared has worked with elected officials at the local and state levels and led various international missions. A Certified Economic Developer, he is an active member of the International Economic Development Council and has been recognized twice, in 2024 and 2022, as one of North America's Top 50 Economic Developers by Consultant Connect. Jared holds an MBA from Southeastern Louisiana University, a bachelor's degree from Louisiana State University, and is a graduate of the University of Oklahoma's Economic Development Institute.

    30 min

  5. May 10

    How Smart Incentives Shape BioHealth Growth: Ellen Harpel on Economic Development, Accountability, and Regional Competition

    In this episode of BioTalk with Rich Bendis, Ellen D. Harpel, Ph.D., Founder of Smart Incentives, joins the conversation to explore a topic that has shaped the growth of the BioHealth Capital Region but has rarely been discussed directly on the podcast: economic development incentives. Ellen explains why state and local governments use incentives, how they influence business location and expansion decisions, and why effective programs need clear goals, active management, performance measures, and public accountability. The discussion looks at how incentives support companies across the full business lifecycle, from startups and emerging firms to major employers making large-scale regional investments. Ellen and Rich also examine how recent biohealth activity in Maryland and Virginia reflects the importance of workforce development, site selection, public-private collaboration, and regional thinking. A win in Maryland, Virginia, or Washington, D.C. strengthens the larger BioHealth Capital Region ecosystem. Ellen also shares how organizations like BHI and Smart Incentives help companies, communities, and decision makers better understand the resources available to support growth, including financing programs, investor tax credits, grants, incubators, accelerators, and other support services. The episode closes with a practical look at transparency, evaluation, and why better data helps policymakers, economic developers, companies, and communities make stronger decisions about incentive programs. Editing and post-production work for this episode was provided by The Podcast Consultant. https://thepodcastconsultant.com/ Ellen D. Harpel, Ph.D., is the Founder of Smart Incentives (https://smartincentives.org/), which helps communities make sound decisions throughout the economic development incentives process. Launched in 2013, Smart Incentives works with state, local, and national governments to design and implement incentive programs that are effective and responsible, with a focus on compliance monitoring, evaluation, transparency, and lasting community benefits. Ellen is also a Senior Research Fellow with the Center for Regional Economic Competitiveness and an Affiliate Faculty member with the Schar School of Policy and Government at George Mason University.

    39 min

  6. Apr 16

    Building Georgetown Tech Ventures and Strengthening the Startup Pipeline from Academic Research

    How do universities move promising discoveries out of the lab and into the market? In this episode of BioTalk, Tatiana Litvin-Vechnyak, Vice President of Georgetown's Office of Technology Commercialization, Christon Hill, Program Manager for Georgetown Tech Ventures, and Jennifer Butler, Entrepreneur-in-Residence with BioHealth Innovation, discuss how Georgetown is building a stronger pipeline from academic science to startup formation. The conversation examines how Georgetown's commercialization efforts are evolving, how GTV supports faculty founders, and why structured programming, outside expertise, and stronger ecosystem connections matter for turning research into real-world impact. The discussion also explores the "missing middle" between discovery and commercialization, the role of Entrepreneurs-in-Residence in advancing founders and technologies, and how partnerships among Georgetown, GTV, and BioHealth Innovation are helping to create a more durable and commercially focused innovation pipeline. The guests also reflect on Georgetown's place within the BioHealth Capital Region and what success will look like as the university continues building a stronger culture of entrepreneurship and company creation. Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Tatiana Litvin-Vechnyak, Ph.D., is Vice President of Georgetown's Office of Technology Commercialization, where she leads the university's efforts to translate research discoveries into real-world impact through licensing, startup creation, and innovation support. Since joining Georgetown in 2023, she has helped expand the university's commercialization infrastructure, including securing the U.S. Economic Development Administration Build to Scale grant that launched Georgetown Tech Ventures. With more than 20 years of experience in intellectual property, licensing, and business development, she previously served in leadership roles at Rutgers University, where she helped advance major innovation and venture development initiatives. She holds a Ph.D. in Pharmacology and is a Registered Patent Agent. Christon Hill is Program Manager for Georgetown Tech Ventures in Georgetown University's Office of Technology Commercialization, where he develops programs, partnerships, and founder support pathways that help move promising research toward venture creation, strategic partnerships, and real-world use. With an interdisciplinary background spanning biotechnology, biology, and the humanities, he brings a practical and market-aware approach to early-stage innovation, with experience in venture development, ecosystem building, and translating complex ideas for investors, partners, and non-technical audiences. He is a graduate of Georgetown's biotechnology master's program, a Marine veteran, and a cross-sector operator focused on helping founders and institutions turn strong ideas into credible, actionable opportunities. Jennifer Butler is a distinguished global commercial executive and strategic leader with nearly 20 years of experience helping biotechnology companies move from early development through commercialization. She serves as an Entrepreneur-in-Residence with BioHealth Innovation and served as Montgomery County's first Executive-in-Residence, a role created through a collaboration between Montgomery County and BioHealth Innovation to provide technical assistance to local biotech startups. Across her career, she has brought a strong commercial perspective to emerging companies, helping founders sharpen strategy, accelerate development, and navigate the path toward growth and commercialization.

    57 min

  7. Apr 13

    Lisa Johnson, CEO of BioForward Wisconsin, on Building a Biohealth Ecosystem and What Comes Next

    What does it take to build a biohealth ecosystem that can compete nationally? In this episode of BioTalk, Lisa Johnson, CEO of BioForward Wisconsin, discusses how Wisconsin helped shape the early use of the term "biohealth" and how that approach has supported the growth of its life sciences sector. Lisa shares how BioForward connects industry, academia, and government to strengthen the state's ecosystem, along with key developments that have brought increased attention to the region, including the expansion of Eli Lilly and Company. She also reflects on Wisconsin's designation as a Biohealth Tech Hub through the U.S. Economic Development Administration and what it means for future growth. The conversation highlights both momentum and ongoing challenges, particularly around access to early-stage capital and building a stronger pipeline of companies. Lisa outlines what will be required for Wisconsin to continue growing as a competitive biohealth hub. Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Lisa Johnson is the Chief Executive Officer of BioForward Wisconsin, the state's member-driven biohealth industry association dedicated to advancing Wisconsin as a global leader in biohealth innovation. In her role, she leads efforts to strengthen the state's ecosystem by connecting industry, academia, and government partners to support company growth, workforce development, and investment attraction. Lisa brings extensive experience in economic development, public policy, and industry leadership, with a focus on building collaborative environments that drive regional competitiveness. She has been instrumental in positioning Wisconsin as a recognized biohealth hub, including leading the state's successful designation as a Biohealth Tech Hub through the U.S. Economic Development Administration. Through her work, she continues to champion initiatives that support emerging companies, expand access to capital, and foster long-term growth across the biohealth sector.

    31 min

  8. Mar 8

    Sustaining Leadership Under Pressure with Dr. Sheetal Ajmani of Radiant Living Institute

    Dr. Sheetal Ajmani joins BioTalk to discuss a topic rarely addressed in the life sciences startup world. The personal and leadership toll that accompanies building and scaling a company. A physician turned executive coach and founder of Radiant Living Institute, Dr. Ajmani works closely with founders and senior leaders navigating intense professional pressure while trying to maintain clarity in decision making. In this conversation, she explains how exhaustion and sustained stress can quietly affect leadership judgment during critical moments such as fundraising, board interactions, regulatory setbacks, and periods of rapid growth. The discussion explores the signals that investors and advisors may overlook when a founder is struggling behind the scenes, and how the culture of "pushing through" can begin to create risk not only for individuals but for the companies they lead. Dr. Ajmani also shares practical ways founders can stabilize their leadership presence and maintain momentum while protecting their own well-being. Editing and post-production work for this episode was provided by The Podcast Consultant (https://thepodcastconsultant.com). Dr. Sheetal Ajmani is a physician, keynote speaker, and executive coach who helps leaders and founders reclaim their well-being and lead with authenticity. After nearly two decades in clinical medicine, she founded Radiant Living Institute, where she integrates science, psychology, and the mind-body connection to help individuals make meaningful and sustainable changes in their lives and leadership. Dr. Ajmani is also the host of the Essential Self-Care podcast and co-author of the Amazon bestselling book Doctoring, Better. For more information, visit https://www.radiantlivinginstitute.com/.

    35 min
See All (200)

4.7
out of 5
11 Ratings

About

BioHealth Innovation, Inc. (BHI) Founder, President & CEO, Rich Bendis, hosts BioTalk — conversations with some of the most accomplished and exciting business, academic, and government leaders in the biohealth industry. BioTalk enables you to learn from these leaders about issues which can help you grow your business. What are the current trends? Where are industry sectors headed? How do we increase access to capital in our region? Rich and his guests dive deep into these topics and much more. Host, Rich Bendis is an entrepreneur, corporate executive, venture capitalist, investment banker, innovation and technology-based economic development leader, international speaker, and consultant in the technology and biohealth industries. Produced by Andy Eckert, with help from The Podcast Consultant, Mathew Passy.

Information

  • Creator
    BioHealth Innovation, Inc. (BHI)
  • Years Active
    2017 - 2026
  • Episodes
    200
  • Rating
    Clean
  • Show Website
    BioTalk with Rich Bendis

You Might Also Like